Endoglin (CD105) overexpression is associated with an immunosuppressive tumor microenvironment in murine lung cancer models and human lung adenocarcinoma
Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Inés Solano-SC, Paula Díez, Martín Perez-Andres, José M. Muñoz-Félix, Alicia Rodríguez-Barbero, Miguel Pericacho · 2026
Read Endoglin (CD105) overexpression is associated with an immunosuppressive tumor microenvironment in murine lung cancer models and human lung adenocarcinoma by Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Inés Solano-SC, Paula Díez, Martín Perez-Andres, José M. Muñoz-Félix, Alicia Rodríguez-Barbero, Miguel Pericacho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13518793.txt.
Description
Claudia Ollauri-Ibáñez and seven colleagues ask in 2026 whether high levels of endoglin, a protein also called CD105 that helps blood vessels grow, mark lung tumors that resist immunotherapy. Such resistant tumors are often called cold because few killer T cells enter them and suppressive cells dominate.
Using mice engineered to overproduce human endoglin, the team grew lung tumors that showed more oxygen shortage and fewer CD8 T cells. The tumors also carried more suppressive M2 macrophages and regulatory T cells than normal-mouse tumors. Human lung adenocarcinoma samples told the same story, with cold tumors carrying higher endoglin. The protein could help doctors predict immunotherapy response and tailor treatment.
Catalog record
| CREATOR | Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Inés Solano-SC, Paula Díez, Martín Perez-Andres, José M. Muñoz-Félix, Alicia Rodríguez-Barbero, Miguel Pericacho |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45335 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |